Company intelligence / Profile preview

ImmuDyne

New York, New York, United Statesimmudyne.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

ImmuDyne has commercialized proprietary yeast beta-glucan ingredients—primarily PureMune—for use in dietary supplements and functional foods. Their products are supported by clinical research on immune modulation and are manufactured under cGMP conditions. The company emphasizes the purity and molecular structure of its beta-glucans as key differentiators

Therapeutic areas: OtherImmunology
Modalities: Beta-glucan (Biologic)Dietary supplement ingredient
Industry: Food & Nutrition

Beyond the preview

Go deeper on ImmuDyne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmuDyne.

Explore the full profile